GUANGDONG BIOLIGHT MEDITECH CO., LTD. Guangdong Biolight Meditech Co., Ltd. Stock
Equities
300246
CNE1000015Q4
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.86 CNY | +4.73% |
|
+10.47% | -33.40% |
| Sales 2022 | 1.18B 164M 223M | Sales 2023 | 1.19B 165M 225M | Capitalization | 2.73B 377M 514M |
|---|---|---|---|---|---|
| Net income 2022 | 22M 3.04M 4.15M | Net income 2023 | -65M -8.99M -12.27M | EV / Sales 2022 | 2.13 x |
| Net cash position 2022 | 352M 48.72M 66.5M | Net Debt 2023 | 86.27M 11.93M 16.29M | EV / Sales 2023 | 2.35 x |
| P/E ratio 2022 |
128
x | P/E ratio 2023 |
-41.7
x | Employees | 1,378 |
| Yield 2022 |
1.23% | Yield 2023 |
-
| Free-Float | 70.29% |
More Fundamentals
* Assessed data
More news
| 1 day | +4.73% | ||
| 1 week | +10.47% | ||
| Current month | -9.14% | ||
| 1 month | -7.55% | ||
| 3 months | -24.45% | ||
| 6 months | -35.53% | ||
| Current year | -33.40% |
1 week
6.16
6.88
1 month
5.967.75
Current year
5.0710.57
1 year
5.0712.79
3 years
5.0715.52
5 years
5.0733.11
10 years
5.0748.53
| Managers | Title | Age | Since |
|---|---|---|---|
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
Wei Wei Xu
DFI | Director of Finance/CFO | 49 | 22-12-25 |
Jin Liang
CTO | Chief Tech/Sci/R&D Officer | 50 | 13-12-29 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jun Dong Xue
BRD | Director/Board Member | 52 | 21-07-04 |
Jin Yuan Yan
CEO | Chief Executive Officer | 61 | 08-01-19 |
Jin Liang
CTO | Chief Tech/Sci/R&D Officer | 50 | 13-12-29 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-28 | 6.86 | +4.73% | 5 385 552 |
| 24-04-26 | 6.55 | +0.92% | 6,618,471 |
| 24-04-25 | 6.49 | -3.57% | 7,987,686 |
| 24-04-24 | 6.73 | +3.22% | 4,191,550 |
| 24-04-23 | 6.52 | +3.82% | 4,642,600 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotes
GUANGDONG BIOLIGHT MEDITECH CO., LTD. is a China-based company principally engaged in the research, development, production and sales of medical monitoring equipment, hemodialysis products and ancillary products. Its medical monitoring equipment includes monitoring equipment, electrocardiograph, pulse oximeters and central monitoring systems. Its hemodialysis products include hemodialysis machines, hemodialyzers, hemodialysis powders/dialysates and perfusion machines. The Company distributes its products in domestic and overseas markets.
Calendar
2024-05-20
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.40% | 239M | |
| -2.70% | 187B | |
| -1.58% | 106B | |
| -4.47% | 66.9B | |
| +0.67% | 49.45B | |
| +16.58% | 48B | |
| +4.06% | 40.84B | |
| +3.61% | 26.48B | |
| +1.53% | 26.25B | |
| +12.96% | 24.62B |
- Stock Market
- Equities
- 300246 Stock
